Ridgeback Biotherapeutics, LP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

1 in Phase 3

Quick facts

Phase 3 pipeline

Placebo (PBO)
Placebo has no active pharmacological mechanism; it is an inert substance used as a control in clinical trials.

Phase 2 pipeline

EIDD-2801

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Ridgeback Biotherapeutics, LP portfolio CI brief
Ridgeback Biotherapeutics, LP pipeline updates RSS

Frequently asked questions about Ridgeback Biotherapeutics, LP

What is Ridgeback Biotherapeutics, LP's pipeline?

Ridgeback Biotherapeutics, LP has 1 drugs in Phase 3, 1 in Phase 2, 0 in Phase 1. Late-stage candidates include Placebo (PBO).

Sector hub: All tracked pharma companies